FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078663076> ?p ?o ?g. }

• W2078663076 endingPage "26561" @default.
• W2078663076 startingPage "26555" @default.
• W2078663076 abstract "Treatment of NIH 3T3 cells with cytochalasin D (10 μm, 1 h at 37 °C) disrupted the actin cytoskeleton and changed the cells from a planar, extended morphology, to a rounded shape. Calcium mobilization by ATP or by platelet-derived growth factor was abolished, while the ability of thapsigargin (2 μm) to empty calcium stores and activate calcium influx was unaffected. Similar experiments with nocodazole to depolymerize the tubulin network yielded identical results. Platelet-derived growth factor induced an increase in inositol phosphates, and this increase was undiminished in the presence of cytochalasin D. Therefore, the blockade of agonist responses by this drug does not result from decreased phospholipase C. Injection of inositol 1,4,5-trisphosphate (IP3) released calcium to the same extent in control and cytochalasin D-treated cells. Confocal microscopic studies revealed a significant rearrangement of the endoplasmic reticulum after cytochalasin D treatment. Thus, disruption of the cytoskeleton blocks agonist-elicited [Ca2+] i mobilization, but this effect does not result from a lower calcium storage capacity, impaired function of the IP3 receptor, or diminished phospholipase C activity. We suggest that cytoskeletal disruption alters the spatial relationship between phospholipase C and IP3 receptors, impairing phospholipase C-dependent calcium signaling. Capacitative calcium entry was not altered under these conditions, indicating that the coupling between depletion of intracellular calcium stores and calcium entry does not depend on a precise structural relationship between intracellular stores and plasma membrane calcium channels. Treatment of NIH 3T3 cells with cytochalasin D (10 μm, 1 h at 37 °C) disrupted the actin cytoskeleton and changed the cells from a planar, extended morphology, to a rounded shape. Calcium mobilization by ATP or by platelet-derived growth factor was abolished, while the ability of thapsigargin (2 μm) to empty calcium stores and activate calcium influx was unaffected. Similar experiments with nocodazole to depolymerize the tubulin network yielded identical results. Platelet-derived growth factor induced an increase in inositol phosphates, and this increase was undiminished in the presence of cytochalasin D. Therefore, the blockade of agonist responses by this drug does not result from decreased phospholipase C. Injection of inositol 1,4,5-trisphosphate (IP3) released calcium to the same extent in control and cytochalasin D-treated cells. Confocal microscopic studies revealed a significant rearrangement of the endoplasmic reticulum after cytochalasin D treatment. Thus, disruption of the cytoskeleton blocks agonist-elicited [Ca2+] i mobilization, but this effect does not result from a lower calcium storage capacity, impaired function of the IP3 receptor, or diminished phospholipase C activity. We suggest that cytoskeletal disruption alters the spatial relationship between phospholipase C and IP3 receptors, impairing phospholipase C-dependent calcium signaling. Capacitative calcium entry was not altered under these conditions, indicating that the coupling between depletion of intracellular calcium stores and calcium entry does not depend on a precise structural relationship between intracellular stores and plasma membrane calcium channels. A variety of hormone and neurotransmitter agonists activate phospholipase C, promoting the breakdown of phosphatidylinositol 4,5-bisphosphate into two intracellular messengers: inositol 1,4,5-trisphosphate (IP3) 1The abbreviations used are: IP3, inositol 1,4,5-trisphosphate; PDGF, platelet-derived growth factor; DMEM, Dulbecco's modified Eagle's medium; PMA, phorbol 12-myristate 13-acetate; PBS, phosphate-buffered saline; DIOC6(3), dihexaoxacarbocyanine; DIC, differential interference contrast; (2,4,5)IP3, inositol 2,4,5-trisphosphate; PIP2, phosphatidylinositol 4,5-bisphosphate. 1The abbreviations used are: IP3, inositol 1,4,5-trisphosphate; PDGF, platelet-derived growth factor; DMEM, Dulbecco's modified Eagle's medium; PMA, phorbol 12-myristate 13-acetate; PBS, phosphate-buffered saline; DIOC6(3), dihexaoxacarbocyanine; DIC, differential interference contrast; (2,4,5)IP3, inositol 2,4,5-trisphosphate; PIP2, phosphatidylinositol 4,5-bisphosphate. and diacylglycerol (1Berridge M.J. Nature. 1993; 361: 315-325Crossref PubMed Scopus (6148) Google Scholar). IP3 binds to channel receptors located in the endoplasmic reticulum, promoting channel opening and increasing cytoplasmic calcium ([Ca2+] i ) as a consequence of depletion of Ca2+ sequestered within the lumen of the endoplasmic reticulum; diacylglycerol activates protein kinase C, an enzyme involved in the modulation of diverse cellular functions.Depletion of intracellular Ca2+ stores activates a pathway for Ca2+ influx (presumably mediated by a channel) across the plasma membrane, which has been termed capacitative Ca2+ entry (2Putney Jr., J.W. Cell Calcium. 1986; 7: 1-12Crossref PubMed Scopus (2087) Google Scholar). Numerous studies utilizing reagents that inhibit the Ca2+-ATPase responsible for Ca2+storage within the endoplasmic reticulum (e.g. thapsigargin) have demonstrated that Ca2+ store depletion provides a full and sufficient signal for activation of capacitative Ca2+entry (3Putney Jr., J.W. Bird G.S.J. Endocr. Rev. 1993; 14: 610-631Crossref PubMed Scopus (483) Google Scholar, 4Putney Jr., J.W. Capacitative Calcium Entry. Landes Biomedical Publishing, Austin, TX1997Crossref Google Scholar). However, the nature of the signal linking pool depletion to opening of the capacitative Ca2+ influx pathway remains unknown. Two general mechanisms have been proposed to explain how information is transferred from the endoplasmic reticulum to the plasma membrane (reviewed in Putney and Bird (3Putney Jr., J.W. Bird G.S.J. Endocr. Rev. 1993; 14: 610-631Crossref PubMed Scopus (483) Google Scholar) and Berridge (5Berridge M.J. Biochem. J. 1995; 312: 1-11Crossref PubMed Scopus (1046) Google Scholar)). One model describes a direct protein-protein association between the IP3 receptor in the endoplasmic reticulum and the capacitative entry channel: after IP3 binding and release of stored Ca2+, the IP3 receptor would undergo a conformational change, which allows for its interaction with the capacitative Ca2+ channel, resulting in its opening. In the other proposal, a diffusible messenger, released and/or formed as a consequence of Ca2+ pool depletion, would stimulate the Ca2+ influx pathway to open. The first model implies a close physical interaction between the endoplasmic reticulum and the plasma membrane; on the other hand, such a direct interaction would not be required for a diffusible factor to act.In a previous report, we provided indirect evidence for a physical interaction between IP3 receptors and the plasma membrane that involved the actin cytoskeleton, and we speculated that this interaction might be important in signaling capacitative calcium entry (6Rossier M.F. Bird G.S.J. Putney Jr., J.W. Biochem. J. 1991; 274: 643-650Crossref PubMed Scopus (119) Google Scholar). Therefore, the present studies were conducted to assess agonist- and thapsigargin-induced [Ca2+] i mobilization in NIH 3T3 cells under cytoskeletal-disrupting conditions. Whereas cytoskeletal disruption blocked agonist-induced Ca2+signaling, release of sequestered Ca2+ by thapsigargin and the resulting activation of capacitative Ca2+ entry were not affected, despite profound alterations in cellular structure and endoplasmic reticulum morphology. Thus, these data indicate that the coupling between Ca2+ pool depletion and capacitative Ca2+ entry does not depend on the cytoskeleton or on cell shape and suggest that signaling can occur without maintenance of a close proximity between intracellular stores and plasma membrane Ca2+ channels.RESULTSNIH 3T3 cells treated with vehicle, 10 μmcytochalasin D to depolymerize the actin microfilaments, or 10 μm nocodazole to disrupt the tubulin microtubules, were visualized by differential interference contrast microscopy (Fig.1). Control cells were characterized as being flat, extended, and elongated, expressing a typical fibroblast phenotype (Fig. 1 A); on the other hand, both cytochalasin D and nocodazole induced significant alterations in cellular morphology, causing the cells to assume a spherical shape (Fig. 1, B andC, respectively). To confirm that cytochalasin D and nocodazole induced the predicted cytoskeletal disruptions, a double-labeling fluorescence protocol was used to stain the actin and the tubulin cytoskeletons (Fig. 2). The filamentous actin, as evidenced by the presence of stress fibers (red staining), as well as the microtubules (green staining) were found to be intact and distributed throughout the cytoplasm in control cells (Fig. 2 A); the tubulin stain, however, was more prominent in the cell periphery. Pretreatment with cytochalasin D (Fig.2 B) or nocodazole (Fig. 2 C) specifically depolymerized either the stress fibers or the microtubules, respectively. In the cytochalasin D-treated cells, the actin bundles were replaced by a punctate accumulation of actin in the cytoplasm; on the other hand, in the nocodazole-treated cells the depolymerized tubulin redistributed toward the cell periphery and also accumulated within surface blebs. Although disruption of either the actin or the tubulin cytoskeletons caused the cells to round up, a specific feature of the cytochalasin D treatment was the formation of cellular processes radiating from the cytoplasm, whereas the nocodazole-treated cells expressed cell surface blebs. This laboratory has recently reported that activation of protein kinase C by PMA promotes cell shape alterations as well as changes in Ca2+ storage capacity in NIH 3T3 fibroblasts (8Ribeiro C.M.P. Putney Jr., J.W. J. Biol. Chem. 1996; 271: 21522-21528Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). Since protein kinase C activation can lead to actin depolymerization in some cells, including fibroblasts (11Rifkin D.B. Crowe R.M. Cell. 1979; 18: 361-368Abstract Full Text PDF PubMed Scopus (95) Google Scholar, 12Schliwa M. Nakamura T. Porter K.R. Euteneuer U. J. Cell Biol. 1984; 99: 1045-1059Crossref PubMed Scopus (232) Google Scholar, 13Hedberg K.K. Birrell G.B. Griffith O.H. Cell Regul. 1991; 2: 1067-1079Crossref PubMed Scopus (11) Google Scholar), we also examined the actin and tubulin cytoskeletons in PMA-treated NIH 3T3 cells. Fig. 2 D confirms that activation of protein kinase C in these cells leads to disruption of actin fibers. Unlike cytochalasin D, PMA causes accumulation of depolymerized actin in the cell periphery, toward membrane ruffles. The integrity of the microtubules was not affected by PMA treatment as previously reported (12Schliwa M. Nakamura T. Porter K.R. Euteneuer U. J. Cell Biol. 1984; 99: 1045-1059Crossref PubMed Scopus (232) Google Scholar).Figure 2Cytochalasin D or nocodazole treatment specifically disrupts the actin or the tubulin cytoskeleton, respectively, in NIH 3T3 cells. Cells were treated with vehicle (Me2SO, control; A), cytochalasin D (B), nocodazole (C), or PMA (D) and double stained for actin (red) or tubulin (green) as described under “Materials and Methods.” A, Control fibroblasts express intact actin stress fibers and tubulin microtubules throughout the cytoplasm. B, cytochalasin D treatment promotes disruption of the stress fibers, with the depolymerized actin shown as a punctate cytoplasmic accumulation, but the microtubules are left intact.C, nocodazole disrupts the microtubules, resulting in accumulation of the depolymerized tubulin on the cell periphery and in surface blebs, without altering the stress fibers. D, in PMA-treated cells, the stress fibers are disrupted but the tubulin cytoskeleton is spared. However, contrary to the effect of cytochalasin D, the PMA-depolymerized actin accumulates in the cell periphery toward membrane ruffles.View Large Image Figure ViewerDownload Hi-res image Download (PPT)We next examined the effect of treatment with cytoskeletal-disrupting agents on [Ca2+] i mobilization. Only cells that expressed the spherical phenotype described above were selected for comparison with control fibroblasts. Fig.3 A depicts the Ca2+-mobilizing action of 1 mm adenosine triphosphate, ATP, an agonist that acts through purinergic receptors to couple to phospholipase Cβ activation. In control cells (Fig.3 A, solid line), ATP induced a rapid and transient increase in [Ca2+] i . This action was completely abolished in cells pretreated with 10 μmcytochalasin D (Fig. 3 A, broken line). Activation of phospholipase Cγ by 50 ng/ml PDGF led, after a lag period of few hundred seconds, to a Ca2+ mobilization of longer duration compared with ATP in control cells (Fig. 3 B, solid line) as previously reported (8Ribeiro C.M.P. Putney Jr., J.W. J. Biol. Chem. 1996; 271: 21522-21528Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). Disruption of the actin cytoskeleton with cytochalasin D also abolished the Ca2+response to PDGF (Fig. 3 B, broken line). Disruption of the tubulin network with nocodazole yielded similar results, with complete blockade of ATP- or PDGF-induced Ca2+ mobilization (Fig. 3, C and D, control, solid lines; nocodazole, broken lines). The failure of cytoskeleton-disrupted cells to respond to phospholipase C-activating agonists was not due to a loss of Ca2+ stores, because 2 μm thapsigargin released Ca2+ in cytochalasin D- or nocodazole-treated cells to the same extent as in control (Fig. 4, A andB, respectively); moreover, in cytochalasin D- or nocodazole-treated cells, the kinetics of activation and the magnitude of capacitative Ca2+ entry after thapsigargin-induced pool depletion were indistinguishable from those in control cells (Fig. 4,A and B, control, solid lines; cytochalasin D or nocodazole, broken lines). These findings indicate that inhibition of agonist-promoted Ca2+mobilization by cytoskeletal disruption does not result from a diminished Ca2+ pool storage capacity or capacitative entry or from increased Ca2+ buffering. In addition, they demonstrate that the signaling mechanism for capacitative Ca2+ entry is not rigorously dependent on cell morphology or on the integrity of the cytoskeleton.Figure 3Disruption of the actin or the tubulin cytoskeleton blocks agonist-induced [Ca2+] i mobilization. NIH 3T3 cells grown on coverslips were treated with Me2SO (control), 10 μmcytochalasin D, or 10 μm nocodazole as described under “Materials and Methods.” Cells were loaded with fura-2/AM, and [Ca2+] i mobilization was assessed after addition of 1 mm ATP (panels A and C) or 50 ng/ml PDGF (panels B and D) in HPSS buffer containing 1.8 mm Ca2+. A andB, control, solid lines; cytochalasin D-treated cells, broken lines. C and D, control,solid lines; nocodazole-treated cells, broken lines.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure 4Disruption of the actin or tubulin cytoskeleton does not block thapsigargin-induced [Ca2+] i mobilization. NIH 3T3 cells grown on coverslips were treated with Me2SO (control), 10 μm cytochalasin D or 10 μm nocodazole and cells were loaded with fura-2/AM as described under “Materials and Methods.” To assess the capacity of the Ca2+ pool and the extent of Ca2+ entry in control, cytochalasin D or nocodazole-treated cells, 2 μm thapsigargin was added to nominally Ca2+ free HPSS buffer, followed by restoration of the extracellular Ca2+ to 1.8 mm where indicated. Panel A, control, solid line; cytochalasin D, broken line. Panel B, control, solid line; nocodazole, broken line.View Large Image Figure ViewerDownload Hi-res image Download (PPT)The failure of agonists to induce Ca2+ mobilization in cytoskeleton-disrupted cells could be accounted for by the following possibilities: (a) one or more of the steps involved in coupling cell surface receptor activation and phospholipase C stimulation may be affected by cytoskeletal disruption, the result being a failure of agonists to increase IP3 levels; (b) the activation of the IP3 receptor in the endoplasmic reticulum may be affected by cytoskeletal disruption, impairing IP3-induced pool depletion; (c) cytoskeletal disruption-induced cell shape changes may alter the spatial-temporal relationship between phospholipase C activation and Ca2+ pool depletion, resulting in diminished Ca2+ mobilization. To address the first possibility, PDGF-induced phospholipase C activation was investigated in control and cytochalasin D-treated cells. As shown in Fig.5, either PDGF or cytochalasin D pretreatment alone increased the levels of IP3 compared with control but, more importantly, when cells were pretreated with cytochalasin D, the effect of PDGF on IP3 production was not blocked and was, if anything, augmented. 2The data shown in Fig. 5 represent the IP3 fraction from Dowex separations of inositol polyphosphates, and thus include both the 1,4,5 and 1,3,4 isomers of IP3. It is unlikely that the increases due to PDGF, cytochalasin D, or the combination of the two represent significant net increases in cellular content of IP3; we have previously shown that the increase of this isomer is too small in NIH 3T3 cells to be statistically detectable against the sizable background of basal IP3, whether assayed by high performance liquid chromatography-resolved radiolabeled inositol polyphosphates, or be mass assay of IP3 (25Lobaugh L.A. Eisfelder B. Gibson K. Johnson G.L. Putney Jr., J.W. Mol. Pharmacol. 1996; 50: 493-500PubMed Google Scholar). We note that in addition to increases in the IP3 fraction from the Dowex columns, the fractions containing isomers of inositol diphosphate and of inositol tetraphosphate, were also significantly increased by PDGF, and in each case this was not prevented by treatment with cytochalasin D. This suggested that the coupling between agonist receptor activation and phospholipase C stimulation was not affected by cytoskeletal disruption. These results are in agreement with studies in mast cells showing that actin or tubulin depolymerization did not inhibit agonist-increased IP3 levels (14Tasaka K. Mio M. Fujisawa K. Aoki I. Biochem. Pharmacol. 1991; 41: 1031-1037Crossref PubMed Scopus (37) Google Scholar).Figure 5Disruption of the actin cytoskeleton does not block agonist-induced IP3 formation. NIH 3T3 cells were labeled with myo-[3H]inositol, treated with Me2SO or 10 μm cytochalasin D, followed by addition of 50 ng/ml PDGF or vehicle. Accumulation of inositol phosphates was assessed as described under “Materials and Methods.” Depicted is the effect of cytochalasin D and PDGF on IP3levels, but similar results were obtained for the IP3metabolites, inositol diphosphate and tetraphosphate.View Large Image Figure ViewerDownload Hi-res image Download (PPT)The possibility that the function of the IP3 receptor could have been depressed by cytoskeletal disruption was addressed by experiments such as the one shown in Fig.6. Fig. 6 A (solid line) shows that microinjection of a single control NIH 3T3 cell incubated in nominally Ca2+-free buffer with a maximal Ca2+-mobilizing concentration (1 mm pipette concentration) of the nonhydrolyzable IP3 analogue, (2,4,5)IP3, led to a rapid and transient Ca2+mobilization as previously reported (8Ribeiro C.M.P. Putney Jr., J.W. J. Biol. Chem. 1996; 271: 21522-21528Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar, 15Bird G.S.J. Rossier M.F. Hughes A.R. Shears S.B. Armstrong D.L. Putney Jr., J.W. Nature. 1991; 352: 162-165Crossref PubMed Scopus (128) Google Scholar); pretreatment with cytochalasin D did not affect this response (Fig. 6 A,broken line). Likewise, the Ca2+-mobilizing action of a submaximal concentration (1 μm pipette concentration) of (2,4,5)IP3 was the same in control and cytochalasin D-treated cells (Fig. 6 B, control, solid line; cytochalasin D, broken line). To confirm that the Ca2+ stores were only partially depleted by the lower concentration of (2,4,5)IP3, 2 μmthapsigargin was subsequently applied; again, there was no difference in the response to thapsigargin in cytochalasin D-treatedversus control cells (Fig. 6 B). Thus, the ability of the IP3 receptor to bind IP3 and release Ca2+ was not altered by cytoskeletal disruption.Figure 6Disruption of the actin cytoskeleton does not block Ca2+ release induced by the nonhydrolyzable analog (2,4,5)IP3. NIH 3T3 cells grown on coverslips were treated with Me2SO (control) or 10 μm cytochalasin D (dashed line) as described under “Materials and Methods.” Cells were previously loaded with fura-2/AM to allow for the measurement of basal [Ca2+] i and subsequently microinjected in nominally Ca2+ free HPSS buffer with 2 mmfura-2 plus 1 mm or 1 μm(2,4,5)IP3 (pipette concentration; A andB, respectively) to assess Ca2+ release. Addition of 2 μm thapsigargin promoted an additional Ca2+ release in cells injected with the lower (panel B) but not with the higher (panel A; not shown) dose of (2,4,5)IP3.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Since we found no evidence for alterations in the formation or action of IP3 under cytoskeletal-dismantled conditions, we tentatively concluded that the cell shape changes induced by cytochalasin D or nocodazole were altering the spatial relationship between phospholipase C and IP3 receptors, impairing phospholipase C-dependent Ca2+ signaling. Thus, we next investigated the effect of cytoskeletal depolymerization on the cellular distribution of the endoplasmic reticulum. To localize the endoplasmic reticulum in control and cytoskeleton-disrupted cells, this organelle was labeled in fixed cells with the fluorescent dihexaoxacarbocyanine dye, DIOC6(3), as previously reported (10Terasaki M. Methods Cell Biol. 1989; 29: 125-135Crossref PubMed Scopus (88) Google Scholar). By abolishing the mitochondrial membrane potential, cell fixation resulted in better labeling of the endoplasmic reticulum. Fig.7 illustrates the fluorescent staining of the endoplasmic reticulum (orange) superimposed with the differential interference contrast image (green) in control (left) or cytochalasin D-treated (right) cells (DIOC6(3) images were ∼ 1 μm thick). In control cells, the endoplasmic reticulum appeared to be spread throughout the cytoplasm, although in the interior regions of the cells some labeling of mitochondria undoubtedly occurs, confusing the interpretation of the images. However, in the flattened regions in the cell periphery, single tubule-like structures were observed and confirmed to correspond to ribosome-studded endoplasmic reticulum in electron micrographs (not shown). As illustrated in Fig. 1, disruption of the actin cytoskeleton caused the cells to round up, and thus the flattened cellular regions containing diffuse endoplasmic reticulum strands were retracted into the more compacted cells. Although it is not possible from such images to determine the precise relationship between endoplasmic reticulum and plasma membrane effectors, it is nonetheless clear that the shape of the endoplasmic reticulum is dramatically changed in cytochalasin D-treated cells, at the very least to accommodate the drastic changes in cell shape. Thus, it is possible that this severe rearrangement of endoplasmic reticulum membranes alters the spatial relationship between the site for phospholipase C generation of IP3 and IP3-sensitive sites on the endoplasmic reticulum.Figure 7The endoplasmic reticulum is significantly rearranged after disruption of the actin cytoskeleton. NIH 3T3 cells were treated with vehicle or 10 μm cytochalasin D for 60 min, fixed with glutaraldehyde and stained with DIOC6(3) as described under “Materials and Methods.”Left panel, the DIOC6(3) stain in control cells;right panel, the fluorescent staining pattern is significantly altered after cytochalasin D treatment.View Large Image Figure ViewerDownload Hi-res image Download (PPT)DISCUSSIONPrevious work from this laboratory provided evidence that the IP3 receptors in the endoplasmic reticulum are linked to the plasma membrane through the actin cytoskeleton (6Rossier M.F. Bird G.S.J. Putney Jr., J.W. Biochem. J. 1991; 274: 643-650Crossref PubMed Scopus (119) Google Scholar). As a result, investigators from this laboratory (6Rossier M.F. Bird G.S.J. Putney Jr., J.W. Biochem. J. 1991; 274: 643-650Crossref PubMed Scopus (119) Google Scholar) and elsewhere (5Berridge M.J. Biochem. J. 1995; 312: 1-11Crossref PubMed Scopus (1046) Google Scholar, 16Irvine R.F. FEBS Lett. 1990; 263: 5-9Crossref PubMed Scopus (576) Google Scholar) have suggested that the communication between endoplasmic reticulum and plasma membrane involved in signaling capacitative Ca2+entry might depend on a structural connection between these two cellular sites. Thus, in the present work we investigated the effects of disruption of the actin and tubulin cytoskeletons on [Ca2+] i signaling in NIH 3T3 cells. Disruption of actin microfilaments with cytochalasin D or tubulin microtubules with nocodazole resulted in profound alterations of both cell morphology and physiology. Depolymerization of either the actin or tubulin networks caused the cells to assume a spherical shape in contrast to the planar, extended, and elongated control fibroblasts (Fig. 1). The specificity of the cytoskeleton-disrupting agents was confirmed by the use of a double-label fluorescence staining protocol; in the cytochalasin D-treated cells only the actin stress fibers were dismantled, with the microtubules left intact, whereas in the nocodazole-treated fibroblasts the microtubules were disrupted but the stress fibers were undisturbed (Fig. 2). When hormones coupled to either phospholipase Cβ or phospholipase Cγ activation were tested for their ability to mobilize [Ca2+] i under the same cytoskeletal-disrupting conditions, it was found that agonist action was completely blocked (Fig. 3). This inhibition of agonist-induced [Ca2+] i signaling appeared to be a general effect of cytoskeletal disruption and/or cell shape change, because it could be induced by depolymerization of either the actin or the tubulin network.In contrast to the effects on agonist-induced [Ca2+] i signaling, neither the release nor the entry of Ca2+ in response to thapsigargin was significantly affected by cytoskeletal disruption. These findings rule out a number of causes for the block of the agonist response, including a loss of Ca2+ stores, or augmented Ca2+ buffering by Ca2+ pumps. Additionally, the failure of cytoskeletal disruption to affect thapsigargin-induced Ca2+ entry indicates that neither an intact cytoskeleton nor cytoskeletal-dependent processes are required for activation of capacitative Ca2+ entry.We also include data demonstrating disruption of the actin cytoskeleton by PMA. In an earlier work, we demonstrated that pretreatment of NIH 3T3 cells with PMA led to a significant loss of stored calcium without activation of capacitative calcium entry (8Ribeiro C.M.P. Putney Jr., J.W. J. Biol. Chem. 1996; 271: 21522-21528Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar). Since the PMA pretreatment also caused the cells to round up and protein kinase C activation in fibroblasts can disrupt actin microfilaments (11Rifkin D.B. Crowe R.M. Cell. 1979; 18: 361-368Abstract Full Text PDF PubMed Scopus (95) Google Scholar, 12Schliwa M. Nakamura T. Porter K.R. Euteneuer U. J. Cell Biol. 1984; 99: 1045-1059Crossref PubMed Scopus (232) Google Scholar, 13Hedberg K.K. Birrell G.B. Griffith O.H. Cell Regul. 1991; 2: 1067-1079Crossref PubMed Scopus (11) Google Scholar), we speculated that PMA-induced calcium store loss may be a result of cytoskeletal rearrangement. The present studies confirmed that protein kinase C activation by PMA disrupts the actin stress fibers in NIH 3T3 cells; however, since dismantling of the actin cytoskeleton with cytochalasin D did not affect calcium pool storage capacity (even though the alteration of cellular shape due to cytochalasin D was more dramatic compared with PMA), we suggest that our earlier reported finding on the effect of PMA on calcium stores is independent of cytoskeletal rearrangement or cell shape. Furthermore, as reported in our earlier investigation (8Ribeiro C.M.P. Putney Jr., J.W. J. Biol. Chem. 1996; 271: 21522-21528Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar) pretreatment of NIH 3T3 cells with PMA seemed to fragment the endoplasmic reticulum, whereas in the present work cytochalasin D appeared to induce a rearrangement rather than a fragmentation of this organelle.The blockade of agonist-induced mobilization of Ca2+ by cytoskeletal disruption was not a result of decreased phospholipase C activity as shown in Fig. 5. Interestingly, cytochalasin D treatment increased cellular levels of IP3 (Fig. 5), but the mechanism for this effect is not known. It is known, however, that monomeric actin-binding proteins" @default.
• W2078663076 created "2016-06-24" @default.
• W2078663076 creator A5060890309 @default.
• W2078663076 creator A5066332556 @default.
• W2078663076 creator A5082125945 @default.
• W2078663076 date "1997-10-01" @default.
• W2078663076 modified "2023-10-18" @default.
• W2078663076 title "Role of the Cytoskeleton in Calcium Signaling in NIH 3T3 Cells" @default.
• W2078663076 cites W1496559683 @default.
• W2078663076 cites W1533458170 @default.
• W2078663076 cites W1568020570 @default.
• W2078663076 cites W165825051 @default.
• W2078663076 cites W1792354214 @default.
• W2078663076 cites W1874327812 @default.
• W2078663076 cites W1964385294 @default.
• W2078663076 cites W1980166477 @default.
• W2078663076 cites W1991602526 @default.
• W2078663076 cites W1993052466 @default.
• W2078663076 cites W1994948311 @default.
• W2078663076 cites W1995843335 @default.
• W2078663076 cites W2002441736 @default.
• W2078663076 cites W2005584034 @default.
• W2078663076 cites W2007263885 @default.
• W2078663076 cites W2014988945 @default.
• W2078663076 cites W2020952609 @default.
• W2078663076 cites W2023022110 @default.
• W2078663076 cites W2029439649 @default.
• W2078663076 cites W2034268083 @default.
• W2078663076 cites W2039025686 @default.
• W2078663076 cites W2051719001 @default.
• W2078663076 cites W2063515244 @default.
• W2078663076 cites W2070832223 @default.
• W2078663076 cites W2083073734 @default.
• W2078663076 cites W2084683135 @default.
• W2078663076 cites W2086669662 @default.
• W2078663076 cites W2090160768 @default.
• W2078663076 cites W2133789308 @default.
• W2078663076 cites W2141260882 @default.
• W2078663076 cites W2316746624 @default.
• W2078663076 cites W2345003741 @default.
• W2078663076 cites W4236631361 @default.
• W2078663076 cites W4376596485 @default.
• W2078663076 cites W87501499 @default.
• W2078663076 doi "https://doi.org/10.1074/jbc.272.42.26555" @default.
• W2078663076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9334235" @default.
• W2078663076 hasPublicationYear "1997" @default.
• W2078663076 type Work @default.
• W2078663076 sameAs 2078663076 @default.
• W2078663076 citedByCount "166" @default.
• W2078663076 countsByYear W20786630762012 @default.
• W2078663076 countsByYear W20786630762013 @default.
• W2078663076 countsByYear W20786630762014 @default.
• W2078663076 countsByYear W20786630762015 @default.
• W2078663076 countsByYear W20786630762016 @default.
• W2078663076 countsByYear W20786630762017 @default.
• W2078663076 countsByYear W20786630762018 @default.
• W2078663076 countsByYear W20786630762019 @default.
• W2078663076 countsByYear W20786630762020 @default.
• W2078663076 countsByYear W20786630762021 @default.
• W2078663076 countsByYear W20786630762022 @default.
• W2078663076 countsByYear W20786630762023 @default.
• W2078663076 crossrefType "journal-article" @default.
• W2078663076 hasAuthorship W2078663076A5060890309 @default.
• W2078663076 hasAuthorship W2078663076A5066332556 @default.
• W2078663076 hasAuthorship W2078663076A5082125945 @default.
• W2078663076 hasBestOaLocation W20786630761 @default.
• W2078663076 hasConcept C104317684 @default.
• W2078663076 hasConcept C142669718 @default.
• W2078663076 hasConcept C1491633281 @default.
• W2078663076 hasConcept C178790620 @default.
• W2078663076 hasConcept C185592680 @default.
• W2078663076 hasConcept C201571599 @default.
• W2078663076 hasConcept C2776746612 @default.
• W2078663076 hasConcept C519063684 @default.
• W2078663076 hasConcept C54009773 @default.
• W2078663076 hasConcept C55493867 @default.
• W2078663076 hasConcept C62478195 @default.
• W2078663076 hasConcept C86803240 @default.
• W2078663076 hasConcept C95444343 @default.
• W2078663076 hasConceptScore W2078663076C104317684 @default.
• W2078663076 hasConceptScore W2078663076C142669718 @default.
• W2078663076 hasConceptScore W2078663076C1491633281 @default.
• W2078663076 hasConceptScore W2078663076C178790620 @default.
• W2078663076 hasConceptScore W2078663076C185592680 @default.
• W2078663076 hasConceptScore W2078663076C201571599 @default.
• W2078663076 hasConceptScore W2078663076C2776746612 @default.
• W2078663076 hasConceptScore W2078663076C519063684 @default.
• W2078663076 hasConceptScore W2078663076C54009773 @default.
• W2078663076 hasConceptScore W2078663076C55493867 @default.
• W2078663076 hasConceptScore W2078663076C62478195 @default.
• W2078663076 hasConceptScore W2078663076C86803240 @default.
• W2078663076 hasConceptScore W2078663076C95444343 @default.
• W2078663076 hasIssue "42" @default.
• W2078663076 hasLocation W20786630761 @default.
• W2078663076 hasOpenAccess W2078663076 @default.
• W2078663076 hasPrimaryLocation W20786630761 @default.
• W2078663076 hasRelatedWork W1967413800 @default.
• W2078663076 hasRelatedWork W2006653660 @default.

• next